QT
PBYI icon

Quantamental Technologies’s Puma Biotechnology PBYI Stock Holding History

Quantamental Technologies’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-12,747
Closed -$137K – 1079
2019
Q3 		$137K Buy
12,747
+8,369
+191% +$90.4K 0.04% 620
2019
Q2 		$56K Buy
+4,378
New +$101K 0.02% 860
2019
Q1 		– Sell
-5,504
Closed -$112K – 1715
2018
Q4 		$112K Buy
+5,504
New +$165K 0.07% 509

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Quantamental Technologies's PBYI Position: Q4 2019 in Review

Quantamental Technologies sold out of Puma Biotechnology (PBYI) in Q4 2019, closing a stake of 12,747 shares — an estimated $137K sold.

Quantamental Technologies first reported a position in PBYI in Q4 2018 and held it in 3 quarters. The position peaked at $137K in Q3 2019. 133 funds tracked by Wall St. Rank hold PBYI as of Q4 2019.

  • Quantamental Technologies reported no remaining Puma Biotechnology position as of Q4 2019 after selling out during the quarter.
  • Quantamental Technologies sold 12,747 Puma Biotechnology shares in Q4 2019, an estimated $137K.
  • Quantamental Technologies first reported a position in Puma Biotechnology in Q4 2018 and held it in 3 quarters.
  • Quantamental Technologies's Puma Biotechnology position peaked at $137K in Q3 2019.
  • 133 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2019.

Based on Quantamental Technologies's 13F filing for Q4 2019, filed 14 Feb 2020.